BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17932744)

  • 1. Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers.
    Wei M; Xu J; Dignam J; Nanda R; Sveen L; Fackenthal J; Grushko TA; Olopade OI
    Breast Cancer Res Treat; 2008 Sep; 111(1):113-20. PubMed ID: 17932744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low incidence of methylation of the promoter region of the FANCF gene in Japanese primary breast cancer.
    Tokunaga E; Okada S; Kitao H; Shiotani S; Saeki H; Endo K; Morita M; Kakeji Y; Maehara Y
    Breast Cancer; 2011 Apr; 18(2):120-3. PubMed ID: 19813073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers.
    Archey WB; McEachern KA; Robson M; Offit K; Vaziri SA; Casey G; Borg A; Arrick BA
    Oncogene; 2002 Oct; 21(46):7034-41. PubMed ID: 12370825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway.
    Wang Z; Li M; Lu S; Zhang Y; Wang H
    Cancer Biol Ther; 2006 Mar; 5(3):256-60. PubMed ID: 16418574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of the CpG methylation status of ER alpha gene in estrogen receptor alpha-negative breast cancer cell lines and the role of hydralazine demethylation].
    Tang B; Jiang J
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):283-7. PubMed ID: 16181550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
    Ramezani F; Salami S; Omrani MD; Maleki D
    Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Demethylation of estrogen receptor gene and its re-expression in estrogen receptor-negative breast].
    Wang R; Li LW; Wang RL; Fan QX; Zhao PR; Wang LX; Lu SH
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):894-7. PubMed ID: 17533738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients.
    Martínez-Galán J; Torres-Torres B; Núñez MI; López-Peñalver J; Del Moral R; Ruiz De Almodóvar JM; Menjón S; Concha A; Chamorro C; Ríos S; Delgado JR
    BMC Cancer; 2014 Feb; 14():59. PubMed ID: 24495356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic induces functional re-expression of estrogen receptor α by demethylation of DNA in estrogen receptor-negative human breast cancer.
    Du J; Zhou N; Liu H; Jiang F; Wang Y; Hu C; Qi H; Zhong C; Wang X; Li Z
    PLoS One; 2012; 7(4):e35957. PubMed ID: 22558281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis.
    Romagnolo DF; Papoutsis AJ; Laukaitis C; Selmin OI
    BMC Cancer; 2015 Dec; 15():1026. PubMed ID: 26715507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of estrogen receptor alpha (ERalpha) gene by promoter hypermethylation is a frequent event in Chinese women with sporadic breast cancer.
    Zhao L; Wang L; Jin F; Ma W; Ren J; Wen X; He M; Sun M; Tang H; Wei M
    Breast Cancer Res Treat; 2009 Sep; 117(2):253-9. PubMed ID: 18814026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors.
    Yoshida T; Eguchi H; Nakachi K; Tanimoto K; Higashi Y; Suemasu K; Iino Y; Morishita Y; Hayashi S
    Carcinogenesis; 2000 Dec; 21(12):2193-201. PubMed ID: 11133808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epigenetic silencing of the estrogen receptor (ER) by hypermethylation of the ESR1 promoter is seen predominantly in triple-negative breast cancers in Indian women.
    Prabhu JS; Wahi K; Korlimarla A; Correa M; Manjunath S; Raman N; Srinath BS; Sridhar TS
    Tumour Biol; 2012 Apr; 33(2):315-23. PubMed ID: 22362381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer.
    Lim SL; Smith P; Syed N; Coens C; Wong H; van der Burg M; Szlosarek P; Crook T; Green JA
    Br J Cancer; 2008 Apr; 98(8):1452-6. PubMed ID: 18414472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter Hypermethylation of FANCF and Susceptibility and Prognosis of Epithelial Ovarian Cancer.
    Ding JJ; Wang G; Shi WX; Zhou HH; Zhao EF
    Reprod Sci; 2016 Jan; 23(1):24-30. PubMed ID: 26507869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.
    Vos S; Moelans CB; van Diest PJ
    Breast Cancer Res; 2017 May; 19(1):64. PubMed ID: 28569220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer.
    Ramos EA; Camargo AA; Braun K; Slowik R; Cavalli IJ; Ribeiro EM; Pedrosa Fde O; de Souza EM; Costa FF; Klassen G
    BMC Cancer; 2010 Jan; 10():23. PubMed ID: 20109227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.
    Wei M; Grushko TA; Dignam J; Hagos F; Nanda R; Sveen L; Xu J; Fackenthal J; Tretiakova M; Das S; Olopade OI
    Cancer Res; 2005 Dec; 65(23):10692-9. PubMed ID: 16322213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential link between estrogen receptor-alpha gene hypomethylation and uterine fibroid formation.
    Asada H; Yamagata Y; Taketani T; Matsuoka A; Tamura H; Hattori N; Ohgane J; Hattori N; Shiota K; Sugino N
    Mol Hum Reprod; 2008 Sep; 14(9):539-45. PubMed ID: 18701604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.
    Sharma D; Blum J; Yang X; Beaulieu N; Macleod AR; Davidson NE
    Mol Endocrinol; 2005 Jul; 19(7):1740-51. PubMed ID: 15746193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.